.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Fuji
Novartis
Daiichi Sankyo
Baxter
Argus Health
QuintilesIMS
Chubb
Harvard Business School
Citi

Generated: July 27, 2017

DrugPatentWatch Database Preview

CHOLOXIN Drug Profile

« Back to Dashboard

What is the patent landscape for Choloxin, and what generic Choloxin alternatives are available?

Choloxin is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in CHOLOXIN is dextrothyroxine sodium. Additional details are available on the dextrothyroxine sodium profile page.

Summary for Tradename: CHOLOXIN

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list39
Patent Applications: see list933
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CHOLOXIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie
CHOLOXIN
dextrothyroxine sodium
TABLET;ORAL012302-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbvie
CHOLOXIN
dextrothyroxine sodium
TABLET;ORAL012302-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbvie
CHOLOXIN
dextrothyroxine sodium
TABLET;ORAL012302-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbvie
CHOLOXIN
dextrothyroxine sodium
TABLET;ORAL012302-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Daiichi Sankyo
Cipla
Healthtrust
Queensland Health
Chinese Patent Office
Covington
Accenture
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot